Regeneron Pharmaceuticals, Inc.
Humanized IL-6 and IL-6 receptor
Last updated:
Abstract:
Mice that comprise a replacement of endogenous mouse IL-6 and/or IL-6 receptor genes are described, and methods for making and using the mice. Mice comprising a replacement at an endogenous IL-6R.alpha. locus of mouse ectodomain-encoding sequence with human ectodomain-encoding sequence is provided. Mice comprising a human IL-6 gene under control of mouse IL-6 regulatory elements is also provided, including mice that have a replacement of mouse IL-6-encoding sequence with human IL-6-encoding sequence at an endogenous mouse IL-6 locus.
Status:
Grant
Type:
Utility
Filling date:
3 Jul 2019
Issue date:
31 Aug 2021